Is Ishita Drugs And Industries a good stock to invest in?

Ishita Drugs And Industries can be analyzed on the following key metrics - TTM P/E: 27.08 Sector P/E: 25.02 Dividend Yield: 0% D/E ratio: -

Ishita Drugs And Industries Share Price

Sector: Biotechnology & Drugs

Powered by

80.90 +0.90 (1.13%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 80.90

Today’s High 80.99

52 Week Low 61.70

52 Week High 104.75

Key Metrics

Market Cap (In Cr) 24.19
Beta 0.93
Div. Yield (%) 0
P/B 2.24
TTM P/E 27.08
Sector P/E 25.02
D/E 0
Open Price 80.99
Prev Close 80

View All Metrics

Ishita Drugs And Industries Analysis

Price Analysis

1 Week

0.5%
3 Months

6.45%
6 Month

-7.54%
YTD

-12.47%
1 Year

20.84%

Risk Meter

57% Low risk
57% Moderate risk
57% Balanced Risk
57% High risk
57% Extreme risk

Ishita Drugs And Industries Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
15

Selling/ General/ Admin Expenses Total
1.34

Depreciation/ Amortization
0.11

Other Operating Expenses Total
1.97

Total Operating Expense
14.11

Operating Income
0.89

Net Income Before Taxes
1.16

Net Income
0.87

Diluted Normalized EPS
2.9

Period
2024

Total Revenue
15.19

Selling/ General/ Admin Expenses Total
1.34

Depreciation/ Amortization
0.11

Other Operating Expenses Total
1.65

Total Operating Expense
14.39

Operating Income
0.8

Net Income Before Taxes
0.99

Net Income
0.75

Diluted Normalized EPS
2.5

Period
2023

Total Revenue
12.07

Selling/ General/ Admin Expenses Total
1.28

Depreciation/ Amortization
0.13

Other Operating Expenses Total
1.47

Total Operating Expense
11.44

Operating Income
0.63

Net Income Before Taxes
0.78

Net Income
0.58

Diluted Normalized EPS
1.93

Period
2022

Total Revenue
14.09

Selling/ General/ Admin Expenses Total
1.18

Depreciation/ Amortization
0.13

Other Operating Expenses Total
1.65

Total Operating Expense
13.13

Operating Income
0.96

Net Income Before Taxes
1.04

Net Income
0.8

Diluted Normalized EPS
2.69

Period
2021

Total Revenue
13.95

Selling/ General/ Admin Expenses Total
1.1

Depreciation/ Amortization
0.15

Other Operating Expenses Total
1.65

Total Operating Expense
13.18

Operating Income
0.77

Net Income Before Taxes
1.05

Net Income
0.83

Diluted Normalized EPS
2.77

Period
2020

Total Revenue
14.83

Selling/ General/ Admin Expenses Total
1.1

Depreciation/ Amortization
0.18

Other Operating Expenses Total
1.53

Total Operating Expense
14.25

Operating Income
0.59

Net Income Before Taxes
0.71

Net Income
0.55

Diluted Normalized EPS
1.83

Period
2019

Total Revenue
9.09

Selling/ General/ Admin Expenses Total
0.96

Depreciation/ Amortization
0.16

Other Operating Expenses Total
1.21

Total Operating Expense
8.73

Operating Income
0.36

Net Income Before Taxes
0.46

Net Income
0.35

Diluted Normalized EPS
1.18

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Ishita Drugs And Industries Technical

Moving Average SMA

5 Day79.34
10 Day78.88
20 Day77.36

50 Day78.14
100 Day79.04
300 Day80.88

Ishita Drugs And Industries Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Concord Drugs
30.7
0.29
0.95
44.96
26.1
30.37

Vineet Laboratories
29.79
-0.6
-1.97
78.48
25.35
27.47

Ishita Drugs And Industries
80.9
0.9
1.13
104.75
61.7
24.19

Zenith Health Care
4.39
-0.06
-1.35
6.87
3.82
23.43

Bacil Pharma
39.48
0
0
62.56
14.85
23.25

Ishita Drugs And Industries Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

13-Jun-25
Others

30-May-25
Audited Results

13-Feb-25
Quarterly Results

12-Nov-24
Quarterly Results

13-Aug-24
Quarterly Results

30-May-24
Audited Results

13-Feb-24
Quarterly Results

08-Nov-23
Quarterly Results

12-Aug-23
Quarterly Results

30-May-23
Audited Results

Meeting Date
Announced on
Purpose

30-Sept-24
27-Aug-24
AGM

27-Sept-23
31-Aug-23
AGM

View All

Company Profile

ABOUT Ishita Drugs And Industries

Industry Biotechnology & Drugs
ISIN INE806D01016
BSE Code 524400

Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.

MANAGEMENT

Sumit Agrawal Chief Financial Officer
Srushti Pandya Compliance Officer, Company Secretary
Jagdishprasad Agrawal Managing Director, Executive Director

ISHITA DRUGS AND INDUSTRIES SUMMARY

Ishita Drugs And Industries is trading 1.13% upper at Rs 80.90 as compared to its last closing price. Ishita Drugs And Industries has been trading in the price range of 80.99 & 80.90. Ishita Drugs And Industries has given -12.47% in this year & 0.5% in the last 5 days.

Ishita Drugs And Industries has TTM P/E ratio 27.08 as compared to the sector P/E of 25.02.

The company posted a net profit of 0.29 Crores in its last quarter.

Listed peers of Ishita Drugs And Industries include Concord Drugs (0.95%), Vineet Laboratories (-1.97%), Ishita Drugs And Industries (1.13%) etc.

Ishita Drugs And Industries has a 49.91% promoter holding & 50.09% public holding.

FAQs about Ishita Drugs And Industries

Ishita Drugs And Industries is trading at 80.90 as on 13 Jun, 2025 10:53:13 AM. This is 1.13% upper as compared to its previous closing price of 80

The market capitalization of Ishita Drugs And Industries is 24.19 Cr as on 13 Jun, 2025 10:53:13 AM.

The 52 wk high for Ishita Drugs And Industries is 104.75 whereas the 52 wk low is 61.70

Ishita Drugs And Industries can be analyzed on the following key metrics -

TTM P/E: 27.08
Sector P/E: 25.02
Dividend Yield: 0%
D/E ratio: -

Ishita Drugs And Industries reported a net profit of 0.87 Cr in 2025.

Ishita Drugs And Industries Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Ishita Drugs And Industries Share Price

Price Range

Key Metrics

Ishita Drugs And Industries Analysis

Ishita Drugs And Industries Financials

Forecast

Forecast

Forecast

Ishita Drugs And Industries Technical

Ishita Drugs And Industries Peers

Ishita Drugs And Industries Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Ishita Drugs And Industries

MANAGEMENT

ISHITA DRUGS AND INDUSTRIES SUMMARY

FAQs about Ishita Drugs And Industries

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue